cyamemazine has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Guerra, M; Bayle, F; Dib, M; Garay, RP; Hameg, A | 1 |
| Alvarez-Guerra, M; d'Alché-Birée, F; Dib, M; Garay, RP; Vargas, F; Wolf, WA | 1 |
2 other study(ies) available for cyamemazine and Muscle Contraction
| Article | Year |
|---|---|
5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.
Topics: Animals; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Phenothiazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 2002 |
5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Caudate Nucleus; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Membranes; Muscle Contraction; Muscle, Smooth, Vascular; Phenothiazines; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Type C Phospholipases | 2000 |